サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1455671

マイクロバイオーム治療薬市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Microbiome Therapeutics Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 322 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロバイオーム治療薬市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

マイクロバイオーム治療薬の市場規模は2023年に1億245万米ドルとなり、2024年から2032年にかけてCAGR 36.78%で拡大

マイクロバイオーム治療薬市場 - 市場力学

マイクロバイオーム研究の進展が市場の需要を促進

開発中の治療薬の大半は初期段階にあり、通常は第I相および第II相です。消化器（GI）適応症については、23品目中13品目以上が研究中で、その大半が潰瘍性大腸炎に焦点を当てています。例えば、セレスセラピューティクス社は2021年、再発性C.ディフィシル感染症を対象とした経口治療薬SER-109の第3相ECOSPOR III試験のデータを発表し、2023年前半の発売を予定しています。注目すべきは、プラセボと比較してSER-109は抗菌薬耐性遺伝子の減少と関連していることです。マイクロバイオーム研究の進歩により、感染症やその他の疾患に対する改善された治療法の発見が促進され、医療の成果が向上すると期待されています。マイクロバイオームに基づく治療法の採用を促進するため、企業は製品のコストを引き下げ、より幅広い層の人々に最先端医療へのアクセスを拡大しようとしています。さらに、複数の行政機関がアプローチを再構築しています。その結果、市場ベンダーには市場シェアを拡大する有利な成長機会がもたらされています。

マイクロバイオーム治療薬市場 - 主要インサイト

世界市場は予測期間（2024年～2032年）に約36.78％のCAGRで毎年成長すると推定されます。

製品タイプ別では、FMTが2023年に最大の市場シェアを示すと予測されます。

用途別では、2023年にC.ディフィシルが主要なタイプでした。

地域別では、北米が2023年に収益を上げる主要市場です。

マイクロバイオーム治療薬市場 - セグメンテーション分析：

マイクロバイオーム治療薬の世界市場は、製品タイプ、用途、地域に基づいて区分されます。

市場は製品タイプに基づいて2つのカテゴリーに分けられます：FMTとマイクロバイオーム治療薬です。2023年には、糞便微生物叢療法（FMT）がマイクロバイオーム治療薬市場の支配的勢力に浮上しました。この優位性は、主にC.ディフィシル感染症の治療に広く利用されていることに起因します。さらに、FMTの新たな治療用途の探求を目的とした研究開発への注目の高まりと、市場へのカプセルの導入が、FMTの成長を促進すると予想されます。例えば、2021年2月、OpenBiome社は、糞便微生物叢療法製剤におけるSARS-COV-2に対する新たな直接検査の導入を発表し、感染伝播のリスクを軽減しつつ、緊急使用のために予定された患者へのFMTの利用可能性を高めることを目指しています。

市場は用途別に5つのカテゴリーに分類されます：C.ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他です。クロストリジウムディフィシル感染症（CDIまたはC.ディフィシル）に関連するセグメントは、2023年も市場の優位性を維持すると予測されます。このセグメントの拡大は、C.ディフィシル感染症の治療のための糞便微生物叢移植（FMT）の採用が増加していることに起因しています。バーミンガム大学が実施した2020年の研究によると、FMTはクロストリジウムディフィシル感染症患者の治療に広く受け入れられています。さらに、FMTは抗生物質と比較してC.ディフィシルの治療において、特に再発例においてより高い有効性を示しています。

マイクロバイオーム治療薬市場 - 地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

マイクロバイオーム治療薬市場 - 競合情勢：

マイクロバイオーム治療薬市場の企業は、競争力を維持するために、新たな治療用途を探索するための研究開発への投資、製品の入手しやすさと価格の向上、研究機関やヘルスケアプロバイダーとの協力関係の促進、製品の有効性と安全性を向上させるための技術的進歩の活用など、さまざまな戦略を採用しています。これらの戦略は、技術革新を推進し、市場参入を拡大し、最終的には微生物ベースの治療分野における患者の転帰を改善することを目的としています。

目次

第1章 マイクロバイオーム治療薬の市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 マイクロバイオーム治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 マイクロバイオーム治療薬の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 マイクロバイオーム治療薬市場：新型コロナウイルス感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 マイクロバイオーム治療薬の市場情勢

  • マイクロバイオーム治療薬市場シェア分析（2023年）
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 マイクロバイオーム治療薬市場：製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • FMT
    • マイクロバイオーム薬

第8章 マイクロバイオーム治療薬市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • C.ディフィシル
    • クローン病
    • 炎症性腸疾患
    • 糖尿病
    • その他

第9章 マイクロバイオーム治療薬市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：マイクロバイオーム治療薬産業

  • 競合ダッシュボード
  • 企業プロファイル
    • OpenBiome
    • Seres Therapeutics Inc.
    • D Pharma plc.
    • Locus Biosciences, Inc.
    • Enterome SA
    • Finch Therapeutics Group, Inc.
    • Intralytix, Inc.
    • Microbiotica
    • Second Genome
    • Rebiotix Inc.
    • Vedanta Bioscience, Inc.
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Microbiome therapeutics Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Microbiome therapeutics Market, by Product Type 2019-2032 (USD Million)
  • TABLE Microbiome therapeutics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Microbiome therapeutics Market, by Application 2019-2032 (USD Million)
  • TABLE Microbiome therapeutics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Microbiome therapeutics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Microbiome therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Europe Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Asia Pacific Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Latin America Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Middle East and Africa Microbiome therapeutics Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Germany Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE India Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Brazil Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Saudi Arabia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2334

REPORT HIGHLIGHT

Microbiome therapeutics Market size was valued at USD 102.45 Million in 2023, expanding at a CAGR of 36.78% from 2024 to 2032.

Microbiome therapeutics entail the development and application of treatments directed at the human microbiome, which comprises a complex community of microorganisms residing within the human body. These therapeutics are designed to restore, manipulate, or enhance microbial balance within the body, thereby fostering health and addressing various medical conditions. They manifest in different forms, including probiotics (live beneficial bacteria), prebiotics (substances promoting the growth of beneficial bacteria), postbiotics (metabolites produced by beneficial bacteria), and fecal microbiota transplantation (the transfer of fecal matter from a healthy donor to a recipient).

Microbiome therapeutics Market- Market Dynamics

Advancements in microbiome research to propel market demand

The majority of therapeutic agents in development are in the early stages, typically Phase I and Phase II. Regarding gastrointestinal (GI) indications, over 13 drugs out of 23 are under investigation, with the majority focusing on ulcerative colitis. For example, in 2021, Seres Therapeutics, Inc. introduced data from its Phase 3 ECOSPOR III study on SER-109, an oral therapy investigated for recurrent C. difficile infection, with an anticipated launch slated for the first half of 2023. Notably, compared to the placebo, SER-109 is associated with a decrease in antimicrobial resistance genes. Advancements in microbiome research are expected to facilitate the discovery of improved treatments for infections and other diseases, thereby enhancing medical care outcomes. To promote the adoption of microbiome-based treatments, companies are reducing the cost of their products and expanding access to cutting-edge medical care to a broader segment of the population. Additionally, several governing bodies are restructuring their approaches. Consequently, this presents market vendors with lucrative growth opportunities to enhance their market share.

Microbiome therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.78% over the forecast period (2024-2032)

Based on Product Type segmentation, FMT was predicted to show maximum market share in the year 2023

Based on Application segmentation, C. difficile was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Microbiome therapeutics Market- Segmentation Analysis:

The Global Microbiome therapeutics Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on Product Type: FMT and Microbiome Drugs. In 2023, Fecal Microbiota Therapy (FMT) emerged as the dominant force in the microbiome therapeutics market. This dominance is primarily ascribed to its extensive utilization in treating C. difficile infection. Additionally, the growing focus on research and development aimed at exploring alternative therapeutic applications of FMT, coupled with the introduction of capsules into the market, is anticipated to propel its growth. For instance, in February 2021, OpenBiome announced the introduction of new direct testing for SARS-COV-2 in fecal microbiota therapy preparations, aiming to enhance FMT availability to scheduled patients for emergency use while mitigating the risk of infection transmission.

The market is divided into five categories based on Application: C. difficile, Crohn's disease, Inflammatory Bowel Disease, Diabetes and Others. The application segment pertaining to Clostridium difficile infection (CDI or C. difficile) is forecasted to maintain dominance in the market in 2023. The expansion of this segment is attributed to the increasing adoption of Fecal Microbiota Transplants (FMT) for treating C. difficile infections. According to a 2020 study conducted by the University of Birmingham, FMT is widely accepted for treating patients afflicted with Clostridium difficile infections. Furthermore, FMT demonstrates greater efficacy in treating C. difficile compared to antibiotics, particularly in cases of recurrence.

Microbiome therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Microbiome therapeutics Market- Competitive Landscape:

Companies in the microbiome therapeutics market employ various strategies to stay competitive, including investing in research and development to explore new therapeutic applications, enhancing product accessibility and affordability, fostering collaborations with research institutions and healthcare providers, and leveraging technological advancements to improve product efficacy and safety. These strategies aim to drive innovation, expand market reach, and ultimately improve patient outcomes in the field of microbiome-based therapies.

Recent Developments:

In December 2021, Kaleido Biosciences revealed a partnership with Janssen to explore the efficacy of microbiome metabolic therapies in preventing immune, atopic, and metabolic conditions that emerge in childhood.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICROBIOME THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

OpenBiome

Seres Therapeutics Inc.

4D Pharma plc.

Locus Biosciences, Inc.

Enterome SA

Finch Therapeutics Group, Inc.

Intralytix, Inc.

Microbiotica

Second Genome

Rebiotix Inc.

Vedanta Bioscience, Inc.

Others

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • FMT
  • Microbiome Drugs

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • C. difficile
  • Crohn's disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Microbiome therapeutics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Microbiome therapeutics Market Snippet by Product Type
    • 2.1.2.Microbiome therapeutics Market Snippet by Application
    • 2.1.3.Microbiome therapeutics Market Snippet by Country
    • 2.1.4.Microbiome therapeutics Market Snippet by Region
  • 2.2.Competitive Insights

3.Microbiome therapeutics Key Market Trends

  • 3.1.Microbiome therapeutics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Microbiome therapeutics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Microbiome therapeutics Market Opportunities
  • 3.4.Microbiome therapeutics Market Future Trends

4.Microbiome therapeutics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Microbiome therapeutics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Microbiome therapeutics Market Landscape

  • 6.1.Microbiome therapeutics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Microbiome therapeutics Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.FMT
    • 7.1.3.Microbiome Drugs

8.Microbiome therapeutics Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.C. difficile
    • 8.1.3.Crohn's disease
    • 8.1.4.Inflammatory Bowel Disease
    • 8.1.5.Diabetes
    • 8.1.6.Others

9.Microbiome therapeutics Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Microbiome therapeutics Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Microbiome therapeutics Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Microbiome therapeutics Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Microbiome therapeutics Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Microbiome therapeutics Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Microbiome therapeutics Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.OpenBiome
    • 10.2.2.Seres Therapeutics Inc.
    • 10.2.3.4D Pharma plc.
    • 10.2.4.Locus Biosciences, Inc.
    • 10.2.5.Enterome SA
    • 10.2.6.Finch Therapeutics Group, Inc.
    • 10.2.7.Intralytix, Inc.
    • 10.2.8.Microbiotica
    • 10.2.9.Second Genome
    • 10.2.10.Rebiotix Inc.
    • 10.2.11.Vedanta Bioscience, Inc.
    • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us